newsfilter
← Latest News
PR Newswire·

Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor from Beijing Tide

Graviton Bioscience Corporation ("Graviton"), a privately held early-stage drug development company founded by Dr. Samuel Waksal, and Beijing Tide...